Adherium (ASX:ADRDA) Pre-Tax Income : A$-10.22 Mil (TTM As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Adherium Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Adherium's pretax income for the six months ended in Jun. 2024 was A$-5.55 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was A$-10.22 Mil. Adherium's pretax margin was -1,195.69%.

During the past 8 years, Adherium's highest Pretax Margin was -159.16%. The lowest was -3749.63%. And the median was -529.82%.

Adherium Pre-Tax Income Historical Data

The historical data trend for Adherium's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium Pre-Tax Income Chart

Adherium Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Pre-Tax Income

Get a 7-Day Free Trial

-11.40

-15.04

-11.22

-9.86

-10.22

Adherium Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial											-6.17	-5.83	-4.03	-4.68	-5.55

Competitive Comparison of Adherium's Pre-Tax Income

For the Medical Devices subindustry, Adherium's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adherium's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adherium's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Adherium's Pre-Tax Income falls into.

Adherium Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Adherium's Pretax Income for the fiscal year that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-12.093	+	1.522	+	-0.002	+	0.241	+	0.108
	=	-10.22

Adherium's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-6.79	+	1.075	+	-0.002	+	0.061	+	0.108
	=	-5.55

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-10.22 Mil.

Adherium (ASX:ADRDA) Pre-Tax Income Explanation

Adherium's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-5.548	/	0.464
	=	-1,195.69%

During the past 8 years, Adherium's highest Pretax Margin was -159.16%. The lowest was -3749.63%. And the median was -529.82%.

Adherium Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Adherium's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Adherium Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.adherium.com

Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium Headlines

No Headlines